Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Signs on Mayo Clinic Lab As Customer

NEW YORK, Nov. 14 (GenomeWeb News) - Third Wave technologies has signed an agreement to supply Mayo Medical Laboratories, the Mayo Clinic's reference lab, with its Invader genetic testing technology, the Madison, Wis., company said Nov. 12.


The laboratory will use the technology to test for three mutations associated with an elevated risk of deep-vein  blood clots, as well as pulmonary embolism: Factor V Leiden, Factor II mutations, and MTHFR mutations.



The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.